| MolName | (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid |
| MolecularFormula | C28H20N4O12S2 |
| Smiles | OC(C(C(C=C1)=O)=C/C1=N/Nc1cc(S(O)(=O)=O)c(/C=C/c(ccc(N/N=C(\C=C2)/C=C(C(O)=O)C2=O)c2)c2S(O)(=O)=O)cc1)=O |
| InChI | InChI=1S/C28H20N4O12S2/c33-23-9-7-17(11-21(23)27(35)36)29-31-19-5-3-15(25(13-19)45(39,40)41)1-2-16-4-6-20(14-26(16)46(42,43)44)32-30-18-8-10-24(34)22(12-18)28(37)38/h1-14,31-32H,(H,35,36)(H,37,38)(H,39,40,41)(H,42,43,44) |
| InChIK | JJLBOYHPMBLKCQ-UHFFFAOYSA-N |
| TotalMolweight | 668.615 |
| Molweight | 668.615 |
| MonoisotopicMass | 668.051916 |
| CLogP | 1.0814 |
| CLogS | -1.344 |
| H Acceptors | 16 |
| H Donors | 6 |
| TotalSurfaceArea | 457.36 |
| Relative PSA | 0.45404 |
| PolarSurfaceArea | 283.02 |
| Druglikeness | 0.25252 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | twice activated DB |
| Shape Index | 0.52174 |
| Fragments | 1 |
| Non HAtoms | 46 |
| NonCHAtoms | 18 |
| Electronegative Atoms | 18 |
| Rotatable Bond | 10 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 6 |
| Symmetricatoms | 24 |
| AcidicOxygens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid | 2 - (3E)-3-[[4-[(E)-2-[4-[(2E)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid